Nobuhisa Shimba now serves as Board of Director and Senior Vice President of Cambrooke Therapeutics. Nobu leads Corporate Planning for governing the company and developing mid- and long-term strategy for future growth.
Nobu is also appointed as a head of Medical Nutrition Division in Ajinomoto North America Inc., which is the shareholder of Cambrooke Therapeutics. Prior to Cambrooke, Nobu was in charge of New Business Development and Research & Development in Ajinomoto Co., Inc.
Nobu has a PhD from Pharmaceutical Chemistry at the University of Tokyo, and was a visiting scientist at University of California, San Francisco. Nobu received several awards from the Chemical Society of Japan, The Japan Society for Bioscience, Biotechnology and Agrochemistry, etc. from his contribution to Life Science and Biotechnology Industry.